176 related articles for article (PubMed ID: 3534099)
1. In vitro stimulation prior to fusion generates antigen-binding human-human hybridomas.
Wasserman RL; Budens RD; Thaxton ES
J Immunol Methods; 1986 Nov; 93(2):275-83. PubMed ID: 3534099
[TBL] [Abstract][Full Text] [Related]
2. In vitro B-lymphocyte antigen priming against both non-immunogenic and immunogenic molecules requiring low amounts of antigen and applicable in hybridoma technology.
Brams P; Pettijohn DE; Brown M; Olsson L
J Immunol Methods; 1987 Apr; 98(1):11-22. PubMed ID: 2435806
[TBL] [Abstract][Full Text] [Related]
3. New strategies to establish human monoclonal antibodies.
Kudo T; Saeki H; Saijyo S; Sato N; Numasaki M; Tachibana T
Tohoku J Exp Med; 1992 Oct; 168(2):323-7. PubMed ID: 1306317
[TBL] [Abstract][Full Text] [Related]
4. Production of human-human hybridomas secreting antibody to sheep erythrocytes after in vitro immunization.
Strike LE; Devens BH; Lundak RL
J Immunol; 1984 Apr; 132(4):1798-803. PubMed ID: 6699402
[TBL] [Abstract][Full Text] [Related]
5. Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma.
Houghton AN; Brooks H; Cote RJ; Taormina MC; Oettgen HF; Old LJ
J Exp Med; 1983 Jul; 158(1):53-65. PubMed ID: 6864164
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte surface marker expression on hybridomas secreting human monoclonal antibodies.
Seifert M; Jahn S; Schwab J; Döcke W; Volk HD; von Baehr R
Hum Antibodies Hybridomas; 1992 Apr; 3(2):86-92. PubMed ID: 1633269
[TBL] [Abstract][Full Text] [Related]
7. High frequency production of hybridomas secreting antibodies to cell antigens.
Cianfriglia M; Nuti M; Turchi V; Barca S; Tombesi M; Morrone S; Cenciarelli C; Natali PG
Hybridoma; 1987 Dec; 6(6):673-7. PubMed ID: 3501765
[TBL] [Abstract][Full Text] [Related]
8. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
[TBL] [Abstract][Full Text] [Related]
9. Generation of human monoclonal antibodies against colon cancer.
Koda K; Glassy MC; Chang HR
Arch Surg; 1990 Dec; 125(12):1591-7. PubMed ID: 2244813
[TBL] [Abstract][Full Text] [Related]
10. Preparation of human-mouse heterohybridomas against an immunising antigen.
Jessup CF; Baxendale H; Goldblatt D; Zola H
J Immunol Methods; 2000 Dec; 246(1-2):187-202. PubMed ID: 11121559
[TBL] [Abstract][Full Text] [Related]
11. Generation of hybridomas producing human monoclonal antibodies against herpes simplex virus after in vitro stimulation.
Masuho Y; Sugano T; Matsumoto Y; Sawada S; Tomibe K
Biochem Biophys Res Commun; 1986 Mar; 135(2):495-500. PubMed ID: 3008724
[TBL] [Abstract][Full Text] [Related]
12. Increase of hybridoma formation by human lymphocytes after stimulation in vitro; effect of antigen, endothelial cells, and PWM.
Astaldi GC; Wright EP; Willems C; Zeijlemaker WP; Janssen MC
J Immunol; 1982 Jun; 128(6):2539-42. PubMed ID: 6804563
[TBL] [Abstract][Full Text] [Related]
13. Pokeweed mitogen-stimulated human lymphocytes fused to LICR-2 (HMY2) generate human-human hybridomas producing monoclonal IgG antibodies reactive to human breast carcinoma and malignant melanoma.
Martin RF; Kisor R; Schroer D; Eichler G; Filaccio ML
Hum Antibodies Hybridomas; 1990; 1(3):154-9. PubMed ID: 2103359
[TBL] [Abstract][Full Text] [Related]
14. Production of IgG-producing hybridomas by in vitro stimulation of murine spleen cells.
Takahashi M; Fuller SA; Hurrell JG
J Immunol Methods; 1987 Feb; 96(2):247-53. PubMed ID: 3492563
[TBL] [Abstract][Full Text] [Related]
15. Rapid generation of monoclonal antibody-secreting hybridomas against African horse sickness virus by in vitro immunization and the fusion/cloning technique.
Stäuber N; Kihm U; McCullough KC
J Immunol Methods; 1993 May; 161(2):157-68. PubMed ID: 8505546
[TBL] [Abstract][Full Text] [Related]
16. Antibody producing human-human hybridomas. I. Technical aspects.
Olsson L; Kronstrøm H; Cambon-De Mouzon A; Honsik C; Brodin T; Jakobsen B
J Immunol Methods; 1983 Jun; 61(1):17-32. PubMed ID: 6343505
[TBL] [Abstract][Full Text] [Related]
17. [Monoclonal antibodies produced by human-human hybridomas].
Chida J
Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
[TBL] [Abstract][Full Text] [Related]
18. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
Cote RJ; Morrissey DM; Oettgen HF; Old LJ
Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
[TBL] [Abstract][Full Text] [Related]
19. High efficiency creation of human monoclonal antibody-producing hybridomas.
Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
[TBL] [Abstract][Full Text] [Related]
20. In vitro immunization for the production of antigen-specific lymphocyte hybridomas.
Reading CL
Methods Enzymol; 1986; 121():18-27. PubMed ID: 3014268
[No Abstract] [Full Text] [Related]
[Next] [New Search]
